CUAMC
China Universal Asset Management Company’s Fate Therapeutics FATE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $25.8K | Buy |
23,024
+179
| +0.8% | +$200 | ﹤0.01% | 446 |
|
|
2025
Q1 | $18.1K | Sell |
22,845
-1,305
| -5% | -$1.03K | ﹤0.01% | 459 |
|
|
2024
Q4 | $39.8K | Buy |
+24,150
| New | +$39.8K | ﹤0.01% | 459 |
|
|
2023
Q4 | – | Sell |
-2,526
| Closed | -$5.36K | – | 446 |
|
|
2023
Q3 | $5.36K | Buy |
2,526
+1,236
| +96% | +$2.62K | ﹤0.01% | 385 |
|
|
2023
Q2 | $6.14K | Sell |
1,290
-40
| -3% | -$190 | ﹤0.01% | 353 |
|
|
2023
Q1 | $7.58K | Buy |
1,330
+343
| +35% | +$1.96K | ﹤0.01% | 327 |
|
|
2022
Q4 | $9.96K | Buy |
987
+78
| +9% | +$787 | ﹤0.01% | 227 |
|
|
2022
Q3 | $20K | Buy |
+909
| New | +$20K | 0.01% | 156 |
|